|Articles|October 6, 2017

New Data on Novel Surface Disinfectant Presented at IDWeek 2017

Researchers from Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center presented new data demonstrating the efficacy of Clorox Healthcare® Fuzion™ Cleaner Disinfectant at IDWeek 2017™. The study showed that Clorox Healthcare® Fuzion™ Cleaner Disinfectant was as effective for killing Clostridium difficile (C. difficile) spores, methicillin-resistant Staphylococcus aureus, and carbapenem-resistant Escherichia coli as a standard bleach product, but was less damaging to surfaces and left less residue on surfaces.(1)

Both bleach formulations reduced each of the pathogens by ≥6.0 log10CFU with a 2-minute contact time. An assessment of real-world materials compatibility of the products by repeated spray applications on a hospital mattress, Formica bedside table, and textiles, found that Fuzion caused minimal to no adverse effects with up to 60 applications. Personnel using the products also reported that Fuzion left much less residue after use and was more tolerable than the standard bleach product.

The research team led by Curtis J. Donskey, MD, professor of medicine at Case Western Reserve University and Infectious Disease Physician at the Louis Stokes Cleveland VA Medical Center, presented the findings as a poster abstract on Oct. 5, 2017 at the IDWeek conference in San Diego.

“Contaminated surfaces are a potential source for dissemination of pathogens in the healthcare environment,” said Donskey. “Our results confirm the product’s efficacy against clinically relevant healthcare pathogens and suggest that Fuzion may provide an alternative sporicidal disinfectant for facilities concerned about surface compatibility.”

Fuzion is the next generation of bleach and the first product of its kind to combine trusted bleach efficacy against tough-to-kill pathogens with the aesthetics required for broad use throughout healthcare facilities. Fuzion is Environmental Protection Agency (EPA)-registered to kill C. difficile spores in two minutes, the fastest kill time available,(2) and 35 other pathogens in one minute.

References:

1. Mana, T.S.; Cadnum, J.L.; Piedrahita, C.; Jencson, A.L.; Donskey, C.J. An equally effective but better tolerated formulation of bleach. Poster session presented at: IDWeek 2017 Oct. 4-8; San Diego, CA.
2. Based on EPA Master Label Comparison as of 4/19/2016.

Source: Clorox Healthcare


Related to this article

Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.
Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.